Abstract:Aging is consistently reported as the most important independent risk factor for neurodegenerative diseases. As life expectancy has significantly increased during the last decades, neurodegenerative diseases became one of the most critical public health problem in our society. The most investigated neurodegenerative diseases during aging are Alzheimer disease (AD), Frontotemporal Dementia (FTD) and Parkinson disease (PD). The search for biomarkers has been focused so far on cerebrospinal fluid (CSF) and blood. Recently, exosomes emerged as novel biological source with increasing interest for age-related neurodegenerative disease biomarkers. Exosomes are tiny Extracellular vesicles (EVs; 30–100 nm in size) released by all cell types which originate from the endosomal compartment. They constitute important vesicles for the release and transfer of multiple (signaling, toxic, and regulatory) molecules among cells. Initially considered with merely waste disposal function, instead exosomes have been recently recognized as fundamental mediators of intercellular communication. They can move from the site of release by diffusion and be retrieved in several body fluids, where they may dynamically reflect pathological changes of cells present in inaccessible sites such as the brain. Multiple evidence has implicated exosomes in age-associated neurodegenerative processes, which lead to cognitive impairment in later life. Critically, consolidated evidence indicates that pathological protein aggregates, including Aβ, tau, and α-synuclein are released from brain cells in association with exosomes. Importantly, exosomes act as vehicles between cells not only of proteins but also of nucleic acids [DNA, mRNA transcripts, miRNA, and non-coding RNAs (ncRNAs)] thus potentially influencing gene expression in target cells. In this framework, exosomes could contribute to elucidate the molecular mechanisms underneath neurodegenerative diseases and could represent a promising source of biomarkers. Despite the involvement of exosomes in age-associated neurodegeneration, the study of exosomes and their genetic cargo in physiological aging and in neurodegenerative diseases is still in its infancy. Here, we review, the current knowledge on protein and ncRNAs cargo of exosomes in normal aging and in age-related neurodegenerative diseases.

Exosome regulation by Rubicon in ageing

Rubicon regulates exosome secretion via the non-autophagic pathway

The Rubicon-WIPI axis regulates exosome biogenesis during ageing

The Rubicon-WIPI axis regulates exosome biogenesis during aging

Rubicon in Metabolic Diseases and Ageing

Exosome Release Delays Senescence by Disposing of Obsolete Biomolecules

Exosomes and Micro-RNAs in Aging Process

Reduced endosomal microautophagy activity in aging associates with enhanced exocyst-mediated protein secretion

Exosome-based immunomodulation during aging: A nano-perspective on inflamm-aging

Exosomal Long Noncoding RNAs in Aging and Age-Related Diseases

Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases

Neuronal waste management: new roles for autophagy genes in the extrusion of protein aggregates and in longevity

Exosomes Released from Senescent Cells and Circulatory Exosomes Isolated from Human Plasma Reveal Aging-associated Proteomic and Lipid Signatures

Molecular Mechanisms of Autophagy Decline during Aging

In-vivo screening implicates endoribonuclease Regnase-1 in modulating senescence-associated lysosomal changes

MicroRNAs as Mediators of the Ageing Process

SIRT1 is downregulated by autophagy in senescence and ageing

The mTORC1-autophagy pathway is a target for senescent cell elimination

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease

Mechanistic exploration of autophagy and aging by RNA interference

The mTOR–lysosome axis at the centre of ageing